Companies / Kenya
Drugmakers Jostle for Growing Kenyan Market
January 2006 | Company Finance AlertA number of drug companies - including major Indian, South African and European players - are to compete for control of Kenya's KES10bn (US$139.32mn) anti-retroviral (ARV) drugs market, which is set to open up as the country bids to provide treatment for its 120,000 HIV/AIDS
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.



